期刊文献+

拉米夫定对慢性重型乙型肝炎患者生存率的提高 被引量:15

Effect of lamivudine on survival rate of patients with chronic severe hepatitis B
下载PDF
导出
摘要 目的观察抗病毒药物拉米夫定对慢性重型乙型病毒性肝炎患者生存率的影响。方法采用配对的回顾性队列研究方法,对1999年10月至2003年12月住院的慢性重型乙型病毒性肝炎患者,根据年龄、性别和病程3个变量对应用拉米夫定和未用拉米夫定治疗的患者进行匹配,比例为1∶1。配对结果为拉米夫定治疗组103例,未用拉米夫定组103例。对研究对象进行随访并比较两组中位生存时间及生存率的差别。结果拉米夫定治疗组中位生存时间为85d,3年生存率为42.7%;未用拉米夫定组中位生存时间为35d,3年生存率为23.4%,两组之间生存率有明显差异(P<0.01)。结论应用拉米夫定治疗可提高慢性重型乙型病毒性肝炎患者的生存率。 Objective To investigate the survival rate of patients with chronic severe hepatitis B (CSH) after lamivudine treatment. Method A matched retrospective cohort study using data on patients derived from a prospectively collected chronic severe hepatitis B database was conducted. The database included patients who received or did not receive lamivudine treatment from October, 1999 to December, 2003. The match was con- ducted according with 3 variables : sex, age and duration of disease. The match ratio was 1 : 1. Cases were patients who received lamivudine treatment (n = 103 ). Controls were patients who did not receive lamivudine treatment (n = 103). All the patients were followed up and their median survival time and survival rate were compared and evaluated. Results The median survival time in lamivudine treatment group and control group were 85 and 35 d respectively. The survival rate for 3 years in treatment group and control group were 42.7% and 23.4% respectively. There was significance difference in survival rate between the 2 groups ( P 〈 0.01 ). Conclusion Lamivudine may improve survival of patients with chronic severe hepatitis B.
出处 《第三军医大学学报》 CAS CSCD 北大核心 2008年第1期75-77,共3页 Journal of Third Military Medical University
关键词 拉米夫定 慢性重型乙型病毒性肝炎 预后 生存率 lamivudine treatment prognosis survival rate
  • 相关文献

参考文献8

  • 1Kapoor D,Guptan R C,Wakil S M,et al.Beneficial effects of lamivudine in hepatitis B virus-related decompensated cirrhosis[J].J Hepatol,2000,33(2):308 -312.
  • 2Hann H W,Fontana R J,Wright T,et al.A United States compassionate use study of lamivudine treatment in nontransplantation candidates with decompensated hepatitis B virus-related cirrhosis[J].Liver Transpl,2003,9 (1):49-56.
  • 3Villeneuve J P,Condreay L D,Willems B,et al.Lamivudine treatment for decompensated cirrhosis resulting from chronic hepatitis B[J].Hepatology,2000,31(1):207-210.
  • 4Manolakopoulos S,Karatapanis S,Elefsiniotis J,et al.Clinical course of lamivudine monotherapy in patients with decompensated cirrhosis due to HBeAg negative chronic HBV infection[J].Am J Gastroenterol,2004,99 (1):57-63.
  • 5Yao F Y,Bass N M.Lamivudine treatment in patients with severely decompensated cirrhosis due to replicating hepatitis B infection[J].J Hepatol,2000,33 (2):301-307.
  • 6顾长海.T细胞毒致乙型肝炎坏死机制[M].//顾长海,王宇明,主编.肝功能衰竭.北京:人民卫生出版社,2002:153—154.
  • 7郭亚光,黄何清.膦甲酸钠治疗慢性重型乙型肝炎短期效果观察[J].实用临床医药杂志,2007,11(3):104-104. 被引量:3
  • 8张南,王宇明,邓国宏,易东.慢性重型肝炎患者的预后因素分析及预后模型的建立[J].中华肝脏病杂志,2005,13(10):730-733. 被引量:32

二级参考文献13

  • 1Stockmann HB, Hiemstra CA, Marquet RL, et al. Extracorporeal perfusion for the treatment of acute liver failure. Ann Surg, 2000,231: 460-470.
  • 2Obuchi M, Yoshiba M, Sekiyama K, et al. [Serial hepatic and splenic volumetry in acute severe hepatitis]. Nippon Shokakibyo Gakakai Zasshi, 1999, 96: 147-153.
  • 3Kamath PS,Wiesner RH,Malinchoc M,et al.A model to predict survival in patients with end-stage liver disease.Hepatology,2001,33:464—470.
  • 4Forman LM, Lucey MR. Predicting the prognosis of chronic liver disease: an evolution from child to MELD. Mayo End-stage Liver Disease. Hepatology, 2001, 33: 473-475.
  • 5Model for end-stage liver disease(MELD) and allocation of donor liver. Gastroenterology, 2003, 124: 91-96.
  • 6Sherker A H,Hirota K,omata M,et al.Foscarnet decreases serm and live duck hepatitis B virus DNA in chronicauly infected ducks[J].Gastroenterology,1986,91:818.
  • 7余红梅,何大卫.检查Cox模型比例风险假定的几种图示法[J].中国卫生统计,2000,17(4):215-218. 被引量:19
  • 8徐国光,巫善明,徐伟民,万谟彬,李成忠,潘钰卿,董尔根,周霞秋,蔡伊梅.膦甲酸钠(可耐)治疗慢性乙型肝炎临床初步报告[J].肝脏,2000,5(2):97-98. 被引量:8
  • 9中华医学会传染病与,寄生虫病学分会,肝病学分会.病毒性肝炎防治方案[J].中华肝脏病杂志,2000,8(6):324-329. 被引量:14006
  • 10张瑞祺,缪晓辉,倪武,蔡雄,王俊学.膦甲酸钠治疗慢性乙型肝炎47例[J].中华传染病杂志,2002,20(3):180-181. 被引量:22

共引文献36

同被引文献131

引证文献15

二级引证文献50

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部